The Hematocrit Paradox – How Does Blood Doping Really Work?

Abstract

The wide-spread assumption that doping with erythropoietin or blood transfusion is only effective by increasing arterial blood O2 content because of rising hematocrit is not self-evident. “Natural blood dopers” (horses, dogs) increase both hematocrit and circulating blood volume during exercise by releasing stored erythrocytes from the spleen. Improvement of aerobic performance by augmenting hemoglobin concentration may be expected until the optimal hematocrit is reached; above this value maximal cardiac output declines due to the steep increase of blood viscosity. Therefore an enlarged blood oxygen content might only be useful if the normal hematocrit of man during exercise is suboptimal. However, recent studies suggest that cardiac power rises after erythropoietin allowing an unchanged cardiac output in spite of increased viscosity. Other factors underlying improved performance after blood doping might be: augmented diffusion capacity for oxygen in lungs and tissues, increased percentage of young red cells with good functional properties (after erythropoietin), increased buffer capacity, increase of blood volume, vasoconstriction, reduced damage by radicals, mood improvement by cerebral effects of erythropoietin. Also the importance of placebo is unknown since double-blind studies are rare. It is suggested that blood doping has multifactorial effects not restricted to the increase in arterial oxygen content.

Key words

erythrocytes - erythropoietin - optimal hematocrit - placebo

References

• 1 Altman PL, Dittmer DS. (eds) Respiration and Circulation.  Bethesda, Maryland: Federation of the American Societies for Experimental Biology. 1971; 
• 2 Amin TM, Sirs JA. The blood rheology of man and various animal species.  Q J Exp Physiol. 1985;  70 37-49
• 3 Araki J, Shimizu J, Mikane T, Mohri S, Matsubara H, Yamaguchi H, Sano S, Ohe T, Takaki M, Suga H. Ventricular pressure-volume area (PVA) accounts for cardiac energy consumption of work production and absorption.  AdvExpMed Biol. 1998;  453 491-497
• 4 Ashenden MJ, Gore CJ, Parisotto R, Sharpe K, Hopkins WG, Hahn AG. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.  Haematologica. 2003;  88 1053-1062
• 5 Beedie CJ, Foad AJ. The placebo effect in sports performance: a brief review.  Sports Med. 2009;  39 313-329
• 6 Birkeland KI, Stray-Gundersen J, Hemmersbach P, Hallen J, Haug E, Bahr R. Effect of thEPO administration on serum levels of sTfR and cycling performance.  Med Sci Sport Exerc. 2000;  32 1238-1243
• 7 Böning D. Altitude and hypoxia training – a short review.  Int J Sports Med. 1997;  18 565-570
• 8 Böning D, Cristancho E, Serrato M, Reyes O, Mora M, Coy l, Rojas J. Hemoglobin mass and peak oxygen uptake in untrained and trained female altitude residents.  Int J Sports Med. 2004;  25 1-8
• 9 Böning D, Maassen N, Jochum F, Steinacker J, Halder A, Thomas A, Schmidt W, Noé G, Kubanek B. After-effects of a high altitude expedition on blood.  Int J Sports Med.. 1997;  18 179-185
• 10 Böning D, Maassen N, Pries A. No proof for augmented arterial oxygen content as only factor influencing exercise capacity after Epo doping.  Letter to the Editor. J Appl Physiol. 2008;  105 1988
• 11 Böning D, Rojas J, Serrato M, Reyes O, Coy L, Mora M. Extracellular pH defense against lactic acid in untrained and trained altitude residents.  Eur J Appl Physiol. 2008;  103 127-137
• 12 Brien AJ, Simon TL. The effects of red blood cell infusion on 10-km race time.  JAMA. 1987;  257 2761-2765
• 13 Brun JF, Bouchahda C, Chaze D, Benhaddad AA, Micallef JP, Mercier J. The paradox of hematocrit in exercise physiology: which is the ”normal” range from an hemorheologist's viewpoint?.  Clin Hemorheol Microcirc. 2000;  22 287-303
• 14 Buick FJ, Gledhill N, Froese AB, Spriet L, Meyers EC. Effect of induced erythrocythemia on aerobic work capacity.  J Appl Physiol. 1980;  48 636-642
• 15 Calbet JA, Lundby C, Koskolou M, Boushel R. Importance of hemoglobin concentration to exercise: acute manipulations.  Respir Physiol Neurobiol. 2006;  151 132-140
• 16 Cayla JL, Maire P, Duvallet A, Wahrmann JP. Erythropoietin induces a shift of muscle phenotype from fast glycolytic to slow oxidative.  Int J Sports Med. 2008;  29 460-465
• 17 Chattopadhyay A, Choudhury TD, Bandyopadhyay D, Datta AG. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical.  Biochem Pharmacol. 2000;  59 419-425
• 18 Crawford JH, Isbell TS, Huang Z, Shiva S, Chacko BK, Schechter AN, Darley-Usmar VM, Kerby JD, Lang Jr JD, Kraus D, Ho C, Gladwin MT, Patel RP. Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation.  Blood. 2006;  107 566-574
• 19 Crowell JW, Smith EE. Determination of the optimal hematocrit.  J Appl Physiol. 1967;  22 501-504
• 20 Dempsey JA, Wagner PD. Exercise-induced arterial hypoxemia.  J Appl Physiol. 1999;  87 1997-2006
• 21 Ekblom B. Counterpoint: maximal oxygen uptake is not limited by a central nervous system governor.  J Appl Physiol. 2009;  106 339-341
• 22 Ekblom B. Blood boosting and sport.  Balliere's Clin Endocrinol Metab. 2000;  14 89-98
• 23 Ekblom B, Wilson G, Astrand PO. Central circulation during exercise after venesection and reinfusion of red blood cells.  J Appl Physiol. 1976;  40 379-383
• 24 El-Sayed MS, Ali N, El-Sayed AZ. Haemorheology in exercise and training.  Sports Med. 2005;  35 649-670
• 25 Gaehtgens P, Kreutz F, Albrecht KH. Optimal hematocrit for canine skeletal muscle during rhythmic isotonic exercise.  Eur J Appl Physiol. 1979;  41 27-39
• 26 Gore CJ, Clark SA, Saunders PU. Nonhematological mechanisms of improved sea-level performance after hypoxic exposure.  Med Sci Sports Exerc. 2007;  39 1600-1609
• 27 Heeschen C, Aicher A, Lehmann R, Fichtlscherer S, Vasa M, Urbich C, Mildner-Rihm C, Martin H, Zeiher AM, Dimmeler S. Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.  Blood. 2003;  102 1340-1346
• 28 Heidenreich S, Rahn KH, Zidek W. Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels.  Kidney Int. 1991;  39 259-265
• 29 Heinicke K, Wolfarth B, Winchenbach P, Biermann B, Schmid A, Huber G, Friedmann B, Schmidt W. Blood volume and hemoglobin mass in elite athletes of different disciplines.  Int J Sports Med. 2001;  22 504-512
• 30 Hsia CC, Johnson Jr RL, Dane DM, Wu EY, Estrera AS, Wagner HE, Wagner PD. The canine spleen in oxygen transport: gas exchange and hemodynamic responses to splenectomy.  J Appl Physiol. 2007;  103 1496-1505
• 31 Kuipers H, Moran J, Dubravcic-Simunjak S, Mitchell DW, Shobe J, Sakai H, Ambartsumov R. Hemoglobin level in elite speed skaters from 2000 up to 2005, and its relationship with competitive results.  Int J Sports Med. 2007;  28 16-20
• 32 Levine BD. V˙O₂ max: what do we know, and what do we still need to know?.  J Physiol. 2008;  586 25-34
• 33 Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA. Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?.  J Appl Physiol. 2008;  105 581-587
• 34 Lundby C, Thomsen JJ, Boushel R, Koskolou M, Warberg J, Calbet JA, Robach P. Erythropoietin treatment elevates haemoglobin concentration by increasing red cell volume and depressing plasma volume.  J Physiol. 2007;  578 309-314
• 35 Miskowiak K, Inkster B, Selvaraj S, Wise R, Goodwin GM, Harmer CJ. Erythropoietin improves mood and modulates the cognitive and neural processing of emotion 3 days post administration.  Neuropsychopharmacology. 2008;  33 611-618
• 36 Morkeberg JS, Belhage B, Damsgaard R. Changes in blood values in elite cyclists.  Int J Sports Med. 2009;  30 130-138
• 37 Pries AR, Secomb TW, Sperandio M, Gaehtgens P. Blood flow resistance during hemodilution: effect of plasma composition.  Cardiovasc Res. 1998;  37 225-235
• 38 Prommer N, Ehrmann U, Schmidt W, Steinacker JM, Radermacher P, Muth CM. Total haemoglobin mass and spleen contraction: a study on competitive apnea divers, non-diving athletes and untrained control subjects.  Eur J Appl Physiol. 2007;  101 753-759
• 39 Prommer N, Heckel A, Schmidt W. Timeframe to detect blood withdrawal associated with autologous blood doping.  Med Sci Sports Exerc. 2007;  39 S3
• 40 Prommer N, Thoma S, Quecke L, Gutekunst T, Völzke C, Wachsmuth N, Niess A, Schmidt W. Total hemoglobin mass, blood volume and heart dimensions in elite Kenyan runners.  Med Sci Sport Exerc. 2010;  42 791-797
• 41 Rentsch RL, Damsgaard R, Lundby C, Juel C. Effects of darbepoetin injections on erythrocyte membrane transport protein expressions in humans.  J Appl Physiol. 2006;  101 164-168
• 42 Robertson HT, Haley NR, Guthrie M, Cardenas D, Eschbach JW, Adamson JW. Recombinant erythropoietin improves exercise capacity in anemic hemodialysis patients.  Am J Kidney Dis. 1990;  15 325-332
• 43 Robertson RJ, Gilcher R, Metz KF, Caspersen CJ, Allison TG, Abbott RA, Skrinar GS, Krause JR. Hemoglobin concentration and aerobic work capacity in women following induced erythrocytemia.  J Appl Physiol. 1984;  57 568-575
• 44 Robertson RJ, Gilcher R, Metz KF, Skrinar GS, Allison TG, Bahnson HT, Abbott R, Becker R. Effect of induced erythrocythemia on hypoxia tolerance during physical exercise.  J Appl Physiol. 1982;  53 490-495
• 45 Robinson Y, Cristancho E, Böning D. Erythrocyte aspartate aminotransferase activity as a possible indirect marker for stimulated erythropoiesis in male and female athletes.  Lab Hematol. 2007;  13 49-55
• 46 Rotter R, Menshykova M, Winkler T, Matziolis G, Stratos I, Schoen M, Bittorf T, Mittlmeier T, Vollmar B. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue.  J Orthop Res. 2008;  26 1618-1626
• 47 Sawka MN, Convertino VA, Eichner ER, Schnieder SM, Young AJ. Blood volume: importance and adaptations to exercise training, environmental stresses, and trauma/sickness.  Med Sci Sports Exerc. 2000;  32 332-348
• 48 Sawka MN, Joyner MJ, Miles DS, Robertson RJ, Spriet LL, Young AJ. American College of Sports Medicine Position Stand. The use of blood doping as an ergogenic aid.  Med Sci Sport Exerc. 1996;  28 i-viii
• 49 Schaffartzik W, Barton ED, Poole DC, Tsukimoto K, Hogan MC, Bebout DE, Wagner PD. Effect of reduced hemoglobin concentration on leg oxygen uptake during maximal exercise in humans.  J Appl Physiol. 1993;  75 491-498
• 50 Schmidt W, Böning D, Braumann KM. Red cell age effects on metabolism and oxygen affinity in humans.  Respir Physiol. 1987;  68 215-225
• 51 Schmidt W, Maassen N, Tegtbur U, Braumann KM. Changes in plasma volume and red cell formation after a marathon competition.  Eur J Appl Physiol. 1989;  58 453-458
• 52 Schmidt W, Maassen N, Trost F, Böning D. Training induced effects on blood volume, erythrocyte turnover and haemoglobin oxygen binding properties.  Eur J Appl Physiol. 1988;  57 490-498
• 53 Schmidt W, Prommer N. Effects of various training modalities on blood volume.  Scand J Med Sci Sports. 2008;  18 (S 01) 57-69
• 54 Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J, Gassmann M. Optimal hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated mice.  Proc Natl Acad Sci USA. 2010;  107 419-423
• 55 Schumacher YO, Pottgiesser T, Ahlgrim C, Ruthardt S, Dickhuth HH, Roecker K. Haemoglobin mass in cyclists during stage racing.  Int J Sports Med. 2008;  29 372-378
• 56 Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin.  Annu Rev Physiol. 2005;  67 99-145
• 57 Spriet LL, Gledhill N, Froese AB, Wilkes DL. Effect of graded erythrocythemia on cardiovascular and metabolic responses to exercise.  J Appl Physiol. 1986;  61 1942-1948
• 58 Thomsen JJ, Rentsch RL, Robach P, Calbet JA, Boushel R, Rasmussen P, Juel C, Lundby C. Prolonged administration of recombinant human erythropoietin increases submaximal performance more than maximal aerobic capacity.  Eur J Appl Physiol. 2007;  101 481-486
• 59 Valeri CR, Cooper AG, Pivacek LE. Limitations of measuring blood volume with iodinated I 125 serum albumin.  Arch Int Med. 1973;  132 534-538
• 60 Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-Schonbein H, Kuschinsky W, Gassmann M. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity.  Blood. 2003;  102 2278-2284
• 61 Wagner PD. A theoretical analysis of factors determining V˙O₂ max at sea level and altitude.  Respir Physiol. 1996;  106 329-349
• 62 Warburton DE, Gledhill N, Quinney HA. Blood volume, aerobic power, and endurance performance: potential ergogenic effect of volume loading.  Clin J Sport Med. 2000;  10 59-66
• 63 Wilkerson DP, Rittweger J, Berger NJ, Naish PF, Jones AM. Influence of recombinant human erythropoietin treatment on pulmonary O₂ uptake kinetics during exercise in humans.  J Physiol. 2005;  568 639-652
• 64 Williams MH, Wesseldine S, Somma T, Schuster R. The effect of induced erythrocythemia upon 5-mile treadmill run time.  Med Sci Sports Exerc. 1981;  13 169-175
• 65 Wu EY, Ramanathan M, Hsia CCW. Role of hematocrit in the recruitment of pulmonary diffusing capacity: comparison of human and dog.  J Appl Physiol. 1996;  80 1014-1020

Correspondence